The Global Branded Generics Market accounted to USD 190.3 billion in 2016 growing at a CAGR of 7.5% during the forecast period of 2017 to 2024.
The Global Branded Generics Market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Enquire about TOC: databridgemarketresearch.com/toc/?…d-generics-market
Major Market Drivers and Restraints:
- Government initiatives
- Increase in the number of patent expiration of branded drugs
- Increasing incidences of chronic diseases
- Limited availability of generic drugs
The global branded generics market is segmented on the basis of formulation type, therapeutic application, drug class, category, end-user, and geography.
Get Full Market Insights @ databridgemarketresearch.com/repor…-generics-market/
On the basis of formulation type the market for branded generics market is segmented into oral, parental, topical.
Based on therapeutic application the branded generics market is segmented into oncology, cardiovascular, diabetes, neurology, gastrointestinal, dermatology, analgesics and anti-inflammatory.
On the basis of drug class the market is segmented into alkylating agents, antimetabolites, hormones, anti-hypertensive, lipid lowering drugs, anti-depressants, anti-psychotics, anti-epileptics, others.
Based on category the market is segmented into simple generics, super generics, biosimilar.
On the basis of end-users the branded generics market is segmented into hospital, clinic, and ambulatory center.
Request for Sample Report @ databridgemarketresearch.com/reque…d-generics-market
On the basis of geography, branded generics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
In 2017, North America is expected to dominate the market.
The Global Branded Generics Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major players operating in this market are
- Teva Pharmaceutical Industries Ltd.
- Novartis International AG.
- Mylan N.V.
- Abbott Healthcare Pvt Ltd.
- Actavis pharmaceuticals
- Sun Pharmaceutical Industries Limited
- STADA Arzneimittel
- Lupin Pharmaceuticals
- Aspen Pharmacare Holding
- Dr. Reddy’s
- Novartis AG
- Eva Pharmaceutical Industries
- Abbott Laboratories
- Valeant Pharmaceuticals International
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
For more information: